Bio-Connect
IHC-P analysis of human brain tissue using GTX31765 BRCC36 antibody. Working concentration : 2.5 microg/ml
IHC-P analysis of human brain tissue using GTX31765 BRCC36 antibody. Working concentration : 2.5 microg/ml
IHC-P analysis of human brain tissue using GTX31765 BRCC36 antibody. Working concentration : 2.5 microg/ml

BRCC36 antibody

GTX31765
GeneTex
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetBRCC3
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    BRCC36 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 0.5 - 2 microg/mL. IHC-P: 2.5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID79184
  • Target name
    BRCC3
  • Target description
    BRCA1/BRCA2-containing complex subunit 3
  • Target synonyms
    BRCA1/BRCA2-containing complex subunit 36; BRCA1-A complex subunit BRCC36; BRCC36; BRISC complex subunit BRCC36; C6.1A; CXorf53; lys-63-specific deubiquitinase BRCC36
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP46736
  • Protein Name
    Lys-63-specific deubiquitinase BRCC36
  • Scientific Description
    This gene encodes a subunit of the BRCA1-BRCA2-containing complex (BRCC), which is an E3 ubiquitin ligase. This complex plays a role in the DNA damage response, where it is responsible for the stable accumulation of BRCA1 at DNA break sites. The component encoded by this gene can specifically cleave Lys 63-linked polyubiquitin chains, and it regulates the abundance of these polyubiquitin chains in chromatin. The loss of this gene results in abnormal angiogenesis and is associated with syndromic moyamoya, a cerebrovascular angiopathy. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 5. [provided by RefSeq, Jun 2011]
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP Inhibition. Fang P et al., 2018 Jun, Mol Cancer Res
    Read more